110020 — Jeonjin Bio Co Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro CapNeutral

Annual balance sheet for Jeonjin Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8,922	15,306	1,334	1,692	6,276
Net Total Accounts Receivable
Net Total Receivables	183	216	1,349	2,817	2,467
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9,987	16,158	4,756	7,767	10,144
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8,048	7,997	10,948	9,765	8,687
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	18,695	24,817	17,924	17,704	18,853
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7,343	13,979	7,947	11,213	1,086
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	7,413	14,022	8,359	11,484	1,192
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	11,282	10,796	9,565	6,220	17,661
Total Liabilities & Shareholders' Equity	18,695	24,817	17,924	17,704	18,853
Total Common Shares Outstanding